Spots Global Cancer Trial Database for neoadjuvant chemoradiation

Every month we try and update this database with for neoadjuvant chemoradiation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.	NCT03042000	Rectal Cancer, ... Neoadjuvant Che...	non-NCRT NCRT capecitabine wi... capecitabine TEM radical resecti...	18 Years - 75 Years	Peking Union Medical College Hospital
Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer	NCT03053544	Rectal Neoplasm...	Metformin	19 Years -	Sunnybrook Health Sciences Centre
Neoadjuvant Chemoradiation Plus PD-1 Antibody(SHR-1210) in Locally Advanced Proximal Stomach Adenocarcinoma	NCT03631615	Gastric Adenoca...	Neoadjuvant che...	18 Years - 75 Years	Shanghai Zhongshan Hospital
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer	NCT02305186	Pancreatic Canc...	Pembrolizumab Neoadjuvant Che...	18 Years -	University of Virginia
Neoadjuvant Chemoradiation Plus PD-1 Antibody(SHR-1210) in Locally Advanced Proximal Stomach Adenocarcinoma	NCT03631615	Gastric Adenoca...	Neoadjuvant che...	18 Years - 75 Years	Shanghai Zhongshan Hospital
A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer	NCT03708042	Stage II Esopha... Stage III Esoph...	Definitive Radi... Neoadjuvant Rad...	18 Years - 70 Years	Tianjin Medical University Cancer Institute and Hospital
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer	NCT02305186	Pancreatic Canc...	Pembrolizumab Neoadjuvant Che...	18 Years -	University of Virginia
Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning	NCT04489368	Esophageal Neop...	Neo-Adjuvant Ra... Neo-Adjuvant Ch... Esophagectomy	18 Years -	Rajiv Gandhi Cancer Institute & Research Center, India
Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1	NCT02605265	Locally Advance...	Radiation Capecitabine Irinotecan Oxaliplatin	18 Years - 75 Years	Fudan University
Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer	NCT04227886	Rectal Neoplasm... Chemoradiothera... Neoadjuvant The... Predictive Biom... Adenocarcinoma	Radiation Capecitabine-Ir...	18 Years - 75 Years	Fudan University
A Trial to Compare Preoperative Chemoradiation and Surgery Versus Surgery Alone in Squamous Cell Carcinoma of Oesophagus	NCT01151839	Esophageal Neop...	Esophagectomy Neoadjuvant che...	18 Years - 65 Years	All India Institute of Medical Sciences, New Delhi
Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer	NCT03053544	Rectal Neoplasm...	Metformin	19 Years -	Sunnybrook Health Sciences Centre
Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer	NCT02614157	Rectal Cancer	LLND labeled line	18 Years - 75 Years	West China Hospital
Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer	NCT02614157	Rectal Cancer	LLND labeled line	18 Years - 75 Years	West China Hospital
Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis	NCT03149978	Locally Advance...		18 Years - 75 Years	Fudan University
Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning	NCT04489368	Esophageal Neop...	Neo-Adjuvant Ra... Neo-Adjuvant Ch... Esophagectomy	18 Years -	Rajiv Gandhi Cancer Institute & Research Center, India
Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC	NCT03623737	Esophageal Squa... Chemoradiation	neoadjuvant che...	20 Years - 75 Years	National Taiwan University Hospital
Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer	NCT04227886	Rectal Neoplasm... Chemoradiothera... Neoadjuvant The... Predictive Biom... Adenocarcinoma	Radiation Capecitabine-Ir...	18 Years - 75 Years	Fudan University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: